COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,763 Articles (22,502 medRxiv, 8,261 bioRxiv)

Most recent first Previous |  Page 2235: Articles 22341-22350  | Next

SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of immune cells
Singh, Y., Trautwein, C., Fendel, R., Krickeberg, N., Held, J., Kreidenweiss, A., Berezhnoy, G., Bissinger, R., Ossowski, S., Salker, M. S., Casadei, N., Riess, O., The DeCOI
10.1101/2020.09.04.282780 — Posted: 2020-09-04 Discussion: Onsite
Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore
Tyson, J. R., James, P., Stoddart, D., Sparks, N., Wickenhagen, A., Hall, G., Choi, J. H., Lapointe, H., Kamelian, K., Smith, A. D., Prystajecky, N., Goodfellow, I., Wilson, S. J., Harrigan, R., Snutch, T. P., Loman, N. J., Quick, J.
10.1101/2020.09.04.283077 — Posted: 2020-09-04
Genomic diversity and evolution of coronavirus (SARS-CoV-2) in France from 309 COVID-19-infected patients
Levasseur, A., Delerce, J., Caputo, A., Brechard, L., Colson, P., Lagier, J.-C., Fournier, P.-E., Raoult, D.
10.1101/2020.09.04.282616 — Posted: 2020-09-04
Effect of Renin-Angiotensin-Aldosterone System inhibitors on outcomes of COVID-19 patients with hypertension: Systematic review and Meta-analysis
Beressa, T. B., Sahilu, T., Deyno, S.
10.1101/2020.09.03.20187393 — Posted: 2020-09-04 Discussion: Onsite
Multiplexed, Microscale, Microarray-based Serological Assay for Antibodies Against All Human-Relevant Coronaviruses
Dawson, E. D., Kuck, L. R., Blair, R. H., Taylor, A. W., Toth, E., Knight, V., Rowlen, K. L.
10.1101/2020.09.03.20179598 — Posted: 2020-09-04
Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2
Findeisen, P., Stiegler, H., Lopez-Calle, E., Schneider, T., Urlaub, E., Hayer, J., Zemmrich, C. S.
10.1101/2020.09.01.20180687 — Posted: 2020-09-04
Insights into the practical effectiveness of RT-PCR testing for SARS-CoV-2 from serologic data, a cohort study
Zhang, Z., Bi, Q., Fang, S., Wei, L., Wang, X., He, J., Wu, Y., Liu, X., Gao, W., Zhang, R., Su, Q., Azman, A., Lessler, J., Zou, X., Gong, W.
10.1101/2020.09.01.20182469 — Posted: 2020-09-03
The role of masks in reducing the risk of new waves of COVID-19 in low transmission settings: a modeling study
Stuart, R. M., Abeysuriya, R. G., Kerr, C. C., Mistry, D., Klein, D. J., Gray, R., Hellard, M., Scott, N.
10.1101/2020.09.02.20186742 — Posted: 2020-09-03 Discussion: Onsite
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma
Yue, H., Nowak, R. P., Overwijn, D., Payne, N. C., Fischinger, S., Atyeo, C., Baden, L. R., Nilles, E. J., Karlson, E. W., Yu, X. G., Li, J. Z., Alter, G., Mazitschek, R., Fischer, E. S.
10.1101/2020.09.01.20184101 — Posted: 2020-09-03 Discussion: Offsite
Early elevation of FIB-4 liver fibrosis score is associated with adverse outcomes among patients with COVID-19
Xiang, F., Sun, J., Chen, P.-H., Han, P., Zheng, H., Cai, S., Kirk, G. D.
10.1101/2020.09.01.20186080 — Posted: 2020-09-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).